Theanine

Structure and properties

The chemical name N5-ethyl-L-glutamine and other synonyms (see box) for theanine reflect its chemical structure. The name theanine, without prefix, is generally understood to imply the L- (S-) enantiomer, derived from the related proteinogenic L-amino acid glutamic acid. Theanine is an analog of this amino acid, and its primary amide, L-glutamine (also a proteinogenic amino acid). Theanine is a derivative of glutamine that is ethylated on the amide nitrogen (as the name N5-ethyl-L-glutamine describes), or alternatively, to the amide formed from ethylamine and L-glutamic acid at its γ- (5-) side chain carboxylic acid group (as the name γ-L-glutamylethylamide describes).

Relative to theanine, the opposite (D-, R-) enantiomer is largely absent from the literature, except implicitly. While natural extracts that are not harshly treated are presumed to contain only the biosynthetic L- enantiomeric form, mishandled isolates and racemic chemical preparations of theanines necessarily contain both theanine and its D-enantiomer (and from racemic syntheses, in equal proportion), and studies have suggested that the D-isomer may actually predominate in some commercial supplement preparations. Amino acid racemization in aqueous media is a well-established chemical process promoted by elevated temperature and non-neutral pH values; prolonged heating of Camellia extracts—possible for oversteeped teas and in undisclosed commercial preparative processes—has been reported to result in increasing racemization of theanine to give increasing proportions of the nonnatural D-theanine, up to equal proportions of each enantiomer.

Discovery and distribution

Theanine is found primarily in plant and fungal species. It was discovered as a constituent of tea (Camellia sinensis) in 1949, and in 1950 a laboratory in Kyoto successfully isolated it from gyokuro leaf, which has high theanine content. Theanine is substantially present in black, green, and white teas from Camellia sinensis in quantities of about 1% of the dry weight. Deliberately shading tea plants from direct sunlight, as is done for matcha and gyokuro green tea, increases L-theanine content. The L-enantiomer is the form found in freshly prepared teas and some human dietary supplements.

Digestion and metabolism

As a structural analog of glutamate and glutamine, the theanine in teas or supplements is absorbed in the small intestine after oral ingestion; its hydrolysis to L-glutamate and ethylamine occur both in the intestine and liver, possibly functioning as a donor for glutamate synthesis.

In vitro

Theanine is structurally similar to the excitatory neurotransmitter glutamate and binds to glutamate receptors in vitro, though with much lower affinity in comparison. Specifically, it binds to ionotropic glutamate receptors in the micromolar range, including the AMPA and kainate receptors and, to a lesser extent, the NMDA receptor. It acts as an antagonist of the former two sites, and a partial co-agonist of the NMDA receptors. In vitro, theanine also binds to group I mGluRs. In addition, it inhibits glutamine transporters and glutamate transporters, and thus blocks the reuptake of glutamine and glutamate.

Theanine may elicit umami taste, a consequence potentially associated with binding to and activation of the T1R1 + T1R3 heterodimer or umami (savory) taste receptor.

Regulatory status

The regulatory status of theanine varies by country. It is sold as a dietary supplement across the United States and European Union. In Japan, L-theanine has been approved for use in all foods, with some restrictions in the case of infant foods. In the United States, the FDA considers it to be GRAS and allows its use as an ingredient in foods and beverages up to a maximum of 250 mg per serving.

In 2003, the German Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), an agency of their Federal Ministry of Food and Agriculture, objected to the addition of isolated theanine to beverages. While it was estimated the quantity of green tea consumed by the average Japanese tea drinker per day contains about 20 mg of the substance, there were no studies measuring the amount of theanine being extracted by typical preparation methods, or the percentage lost by discarding the first infusion. Therefore, with the Japanese being exposed to possibly much less than 20 mg per day, it was the opinion of the BfR that pharmacological reactions to drinks typically containing 50 mg of theanine per 500 milliliters could not be excluded reactions such as impairment of psychomotor skills and amplification of the sedating effects of alcohol and hypnotics.

On November 13, 2023, an Inspection by the Administration of Food Safety, Veterinary Medicine and Plant Protection of the Republic of Slovenia banned the sale of Prime energy drinks in Slovenia as they contain L-theanine, which is not allowed in non-alcoholic beverages. Prime Hydration may be freely sold.

Research on supplement use

Theanine supplements have been marketed with a variety of claims that they improve cognitive performance, reduce stress, improve sleep quality, and alleviate menstrual cramps. Evaluating these claims in 2011, the European Food Safety Authority assessed they were not supported by evidence in studies provided at that time.

A 2020 review of low-quality studies suggested that L-theanine supplementation of 200–400 milligrams per day may reduce stress and anxiety in people with acute stress, but there was insufficient evidence for the use of L-theanine as a medication to treat stress and anxiety. A 2024 review indicated that L-theanine supplementation may be more effective than placebo in alleviating psychopathological symptoms associated with anxiety disorders, ADHD, and schizophrenia.

A 2025 review reported that theanine research has lacked rigor, was mainly based on anecdotes, had ill-defined mechanisms, and exhibited unreliable clinical trials.

References

References

1. (December 2012). "Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea". The Journal of Nutrition.
2. (13 May 2023). "L-Theanine". PubChem, US National Library of Medicine.
3. (20 February 2023). "L-Theanine". Drugs.com.
4. "Components of Gyokuro｜ IPPODO". Ippodo-tea.co.jp.
5. "The Japan Food Chemical Research Foundation".
6. (5 February 2007). "GRAS notice for L-theanine". US Food and Drug Administration.
7. (2011). "Scientific Opinion on the substantiation of health claims related to L-theanine from ''Camellia sinensis'' (L.) Kuntze (Tea) and improvement of cognitive function (ID 1104, 1222, 1600, 1601, 1707, 1935, 2004, 2005), alleviation of psychological stress (ID 1598, 1601), maintenance of normal sleep (ID 1222, 1737, 2004) and reduction of menstrual discomfort (ID 1599) pursuant to Article 13(1) of Regulation (EC) No 1924/2006". EFSA Journal.
8. (2025). "L-theanine: From tea leaf to trending supplement - does the science match the hype for brain health and relaxation?". Nutrition Research.
9. "D-theanine | C7H14N2O3". ChemSpider.com.
10. (August 2011). "L-Theanine: properties, synthesis and isolation from tea". Journal of the Science of Food and Agriculture.
11. (2004). "Analysis of derivatized and underivatized theanine enantiomers by high-performance liquid chromatography/atmospheric pressure ionization-mass spectrometry". Rapid Communications in Mass Spectrometry.
12. "How Gyokuro is Processed ｜ IPPODO". Ippodo-tea.co.jp.
13. (October 1992). "Chromatography of tea constituents". Journal of Chromatography.
14. (April 1960). "[Separation and characterization of N-ethyl-gamma-glutamine from Xerocomus badius]". Biochimica et Biophysica Acta.
15. (November 2022). "Effect of Shading on the Morphological, Physiological, and Biochemical Characteristics as Well as the Transcriptome of Matcha Green Tea". International Journal of Molecular Sciences.
16. (November 2013). "Cystine and theanine: amino acids as oral immunomodulative nutrients". SpringerPlus.
17. (2006). "The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent". Journal of Herbal Pharmacotherapy.
18. (August 2011). "Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction". Pharmacological Research.
19. (August 2017). "Characterization of l-Theanine Excitatory Actions on Hippocampal Neurons: Toward the Generation of Novel N-Methyl-d-aspartate Receptor Modulators Based on Its Backbone". ACS Chemical Neuroscience.
20. (July 2004). "Possible involvement of group I mGluRs in neuroprotective effect of theanine". Biochemical and Biophysical Research Communications.
21. (April 2001). "Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin". Toxicology Letters.
22. (June 2014). "L-Theanine elicits umami taste via the T1R1 + T1R3 umami taste receptor". Amino Acids.
23. "Food and Feed Information Portal Database {{!}} FIP".
24. (1949). "The chemical constituents of tea: III. A new amide theanine.". Nippon Nogeikagaku Kaishi.
25. (April 2001). "200 mg of Zen: L-theanine boosts alpha waves, promotes alert relaxation.". Alternative & Complementary Therapies.
26. (June 2001). "Getränke mit isoliertem L-Theanin". Bundesinstitut für Riskobewertung (BfR).
27. (2011). "Diet, Brain, Behavior: Practical Implications". CRC Press.
28. (August 2003). "Getränke mit isoliertem L-Theanin". Bundesinstitut für Risikobewertung.
29. (13 November 2023). "Inšpekcija prepovedala prodajo pijače Prime zaradi nedovoljene sestavine". Delo.si.
30. (March 2020). "The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review". Plant Foods for Human Nutrition.
31. (December 2024). "The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review". BMC Psychiatry.